Delve Bio is a biotechnology company that provides molecular insights for the precision care of patients.
Delve Bio has raised $35.0M in total funding. The most recent round was Series A. The last funding was announced in June 2023.
Delve Bio's investors include S32, Google Ventures, Xontogeny.
Delve Bio is headquartered in San Francisco, United States.
Delve Bio is a biotechnology company that provides molecular insights for the precision care of patients.
Delve Bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Delve Bio — Funding & Investors." VCBacked, June 20, 2023, https://www.vcbacked.co/company/delve-bio. Accessed July 19, 2026.
VCBacked. (2023). Delve Bio — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/delve-bio
{{cite web |title=Delve Bio — Funding & Investors |url=https://www.vcbacked.co/company/delve-bio |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated